1. Home
  2. INDP vs CREV Comparison

INDP vs CREV Comparison

Compare INDP & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • CREV
  • Stock Information
  • Founded
  • INDP 2000
  • CREV 2007
  • Country
  • INDP United States
  • CREV Ireland
  • Employees
  • INDP N/A
  • CREV N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • CREV
  • Sector
  • INDP Health Care
  • CREV
  • Exchange
  • INDP Nasdaq
  • CREV Nasdaq
  • Market Cap
  • INDP 8.8M
  • CREV 7.2M
  • IPO Year
  • INDP N/A
  • CREV N/A
  • Fundamental
  • Price
  • INDP $0.80
  • CREV $3.66
  • Analyst Decision
  • INDP Strong Buy
  • CREV Strong Buy
  • Analyst Count
  • INDP 2
  • CREV 1
  • Target Price
  • INDP $8.50
  • CREV $39.00
  • AVG Volume (30 Days)
  • INDP 28.5K
  • CREV 322.8K
  • Earning Date
  • INDP 03-12-2025
  • CREV 01-01-0001
  • Dividend Yield
  • INDP N/A
  • CREV N/A
  • EPS Growth
  • INDP N/A
  • CREV N/A
  • EPS
  • INDP N/A
  • CREV N/A
  • Revenue
  • INDP N/A
  • CREV $39,261,077.00
  • Revenue This Year
  • INDP N/A
  • CREV $40.76
  • Revenue Next Year
  • INDP N/A
  • CREV $86.18
  • P/E Ratio
  • INDP N/A
  • CREV N/A
  • Revenue Growth
  • INDP N/A
  • CREV 41.52
  • 52 Week Low
  • INDP $0.72
  • CREV $2.00
  • 52 Week High
  • INDP $3.10
  • CREV $22.34
  • Technical
  • Relative Strength Index (RSI)
  • INDP 44.62
  • CREV 44.01
  • Support Level
  • INDP $0.72
  • CREV $3.39
  • Resistance Level
  • INDP $0.81
  • CREV $4.41
  • Average True Range (ATR)
  • INDP 0.07
  • CREV 0.39
  • MACD
  • INDP -0.00
  • CREV -0.02
  • Stochastic Oscillator
  • INDP 34.43
  • CREV 26.18

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Share on Social Networks: